| Annual · values | 2025 |
|---|---|
| Gross Margin | — |
| Operating Margin | — |
| EBITDA Margin | — |
| Net Margin | — |
| Current Ratio | 0.25 |
| Quick Ratio | 0.25 |
| Debt / Equity | — |
| ROE | — |
| ROA | — |
| Asset Turnover | — |
| Book Value / Share | — |
Crown Reserve Acquisition Corp. I Right is an equity right associated with a blank check company, or special purpose acquisition company (SPAC), incorporated in the Cayman Islands. This right forms part of the units issued in the company's initial public offering, which raised $172.5 million through 17.25 million units priced at $10 each in November 2025. Each right entitles the holder to receive one-fifth of one Class A ordinary share upon the completion of the company's initial business combination. The SPAC targets businesses in the pharmaceutical, medical technology, medical equipment, and healthcare IT industries for a merger or acquisition. Separate trading of the rights, alongside Class A ordinary shares and warrants, commenced on or about December 9, 2025. As a sub-micro cap security with no institutional ownership reported, it reflects limited scale and investor participation typical of post-separation SPAC components. These rights play a role in SPAC structures by providing holders potential equity participation in the post-merger entity, facilitating capital raising for private companies entering public markets.